Completed
GSK BHR Study (Sont)
NCT00920543
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Carmichael, California, United States